Clinical Trials · NCT03565835
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Montefiore Medical Center
- Enrollment
- 31
- Start date
- Jun 2018
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of Patients With Castrate Level of Serum Testosterone